MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...
JOHNSON SPACE CENTER — Even though the IM-1 mission’s lunar lander Odysseus tipped over after landing on the moon last week, the company’s CEO called it a “successful mission” during a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback